PEOPLE - InMedica (US) makes appointment:
This article was originally published in Clinica
InMedica, the US company whose MicroCor subsidiary is developing a fast and non-invasive test for measuring hematocrit using electrical impedence, has appointed Ralph Henson president and CEO. Larry Clark, who has been president of the company for the last three years, will remain as chairman. Mr Henson joins from In-Line Diagnostics.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.